Presentation at the Global Investor Network

We will be introducing Pleco at the Global Investor Forum on 18th March 2021. Please register to join the presentation of our CEO Ivo Timmermans at the pitching session from 4.15 – 5.30 pm CET. The Global Investor Forum is..

Read more..

Pleco Therapeutics receives funding from Oost NL

NIJMEGEN, March 1st, 2021 – Pleco Therapeutics has been granted financial support by the ION+ Innovation fund for small and medium-sized businesses in the province of Gelderland. The fund is managed by Oost NL, backed by the EU and the..

Read more..

Best wishes for 2021

We hope you and your family had a pleasant Holiday season. We wish to thank you for your support during a difficult 2020 and extend our best wishes for the New Year. At Pleco, we had to overcome some obstacles..

Read more..

Drug Repurposing for Rare Diseases 2021

Ivo Timmermans, Pleco’s CEO will be speaking at the Digital Conference Findacure’s annual Drug Repurposing Conference for RareDiseases on the 16th of June 2021. Findacure is a UK charity building the rare disease community to drive research and develop treatments...

Read more..

Ruffena Capital

Pleco Therapeutics’ CEO, Ivo Timmermans will present at the Investment Webinar organized by Ruffena Capital on the Tuesday 8th of June 2021 at 2pm. Ruffena Capital is a corporate finance business, that focuses on advising and raising capital for exceptional,..

Read more..

KnowAML – KnowPlecoids

Pleco Therapeutics aims to extend and enhance the lives of patients through its novel Plecoid therapies that increase the effectiveness of current cancer treatments. This year, AML World Awareness Day is taking place in the midst of the COVID pandemic,..

Read more..